Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 2 , Pages 245-259 , April 2009

ACTH-independent macronodular adrenal hyperplasia

  • André Lacroix, MD (Professor of Medicine)

      Affiliations

    • Corresponding Author InformationTel.: +1 514 890 8000x14930; Fax: +1 514 412 7128.

References 

  1. Newell-Price J, Bertagna X, Grossman AB, et al. Cushing's syndrome. Lancet. 2006;367:1605–1617
  2. Lacroix A, Ndiaye N, Tremblay J, et al. Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocrine Reviews. 2001;22:75–110
  3. Kirschner MA, Powell RD, Lipsett MB. Cushing's Syndrome: Nodular cortical hyperplasia of adrenal glands with clinical and pathological features suggesting adrenocortical tumor. The Journal of Clinical Endocrinology and Metabolism. 1964;24:947–955
  4. Lieberman SA, Eccleshall TR, Feldman D. ACTH-independent massive bilateral adrenal disease (AIMBAD): a subtype of Cushing's syndrome with major diagnostic and therapeutic implications. European Journal of Endocrinology. 1994;131:67–73
  5. Stratakis CA, Kirschner LS. Clinical and genetic analysis of primary bilateral adrenal diseases (micro- and macronodular disease) leading to Cushing syndrome. Hormone and Metabolic Research. 1998;30:456–463
  6. Doppman JL, Chrousos GP, Papanicolaou DA, et al. Adrenocorticotropin-independent macronodular adrenal hyperplasia: an uncommon cause of primary adrenal hypercortisolism. Radiology. 2000;216:797–802
  7. Swain JM, Grant CS, Schlinkert RT, et al. Corticotropin-independent macronodular adrenal hyperplasia: a clinicopathologic correlation. Archives of Surgery. 1998;133:541–546
  8. Malchoff Cd MD, Malchoff DM. Adrenocorticotropic hormone-independent adrenal hyperplasia. The Endocrinologist. 1996;6:79–85
  9. Kirk JM, Brain CE, Carson DJ, et al. Cushing's syndrome caused by nodular adrenal hyperplasia in children with McCune-Albright syndrome. The Journal of Pediatrics. 1999;134:789–792
  10. Zeiger MA, Nieman LK, Cutler GB, et al. Primary bilateral adrenocortical causes of Cushing's syndrome. Surgery. 1991;110:1106–1115
  11. Aiba M, Hirayama A, Iri H, et al. Adrenocorticotropic hormone-independent bilateral adrenocortical macronodular hyperplasia as a distinct subtype of Cushing's syndrome. Enzyme histochemical and ultrastructural study of four cases with a review of the literature. American Journal of Clinical Pathology. 1991;96:334–340
  12. Findlay JC, Sheeler LR, Engeland WC, et al. Familial adrenocorticotropin-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia. The Journal of Clinical Endocrinology and Metabolism. 1993;76:189–191
  13. Minami S, Sugihara H, Sato J, et al. ACTH independent Cushing's syndrome occurring in siblings. Clinical Endocrinology. 1996;44:483–488
  14. Nies C, Bartsch DK, Ehlenz K, et al. Familial ACTH-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia clinically affecting only female family members. Experimental and Clinical Endocrinology & Diabetes. 2002;110:277–283
  15. Miyamura N, Taguchi T, Murata Y, et al. Inherited adrenocorticotropin-independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines: detection of the aberrant hormone receptors on adrenal gland. Endocrine. 2002;19:319–326
  16. Lee S, Hwang R, Lee J, et al. Ectopic expression of vasopressin V1b and V2 receptors in the adrenal glands of familial ACTH-independent macronodular adrenal hyperplasia. Clinical Endocrinology. 2005;63:625–630
  17. Vezzosi D, Cartier D, Regnier C, et al. Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors. European Journal of Endocrinology. 2007;156:21–31
  18. Bourdeau I, Boisselle A, Rioux D, et al. Systematic Clinical Screening of Members of a Family with Hereditary Cortisol-Secreting B-Adrenergic Responsive ACTH-Independent Macronodular Adrenal Hyperplasia (AIMAH) Reveals Unsuspected Subclinical Cushing's Syndrome (CS) and Aberrant B-Adrenergic Regulation of Cortisol Secretion. Program of the 89th Annual Meeting of the Endocrine Society. Toronto, CA: 2007. p 148, Abstract OR54-2.
  19. Skogseid B, Larsson C, Lindgren PG, et al. Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. The Journal of Clinical Endocrinology and Metabolism. 1992;75:76–81
  20. Burgess JR, Harle RA, Tucker P, et al. Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1. Archives of Surgery. 1996;131:699–702
  21. Yamakita N, Murai T, Ito Y, et al. Adrenocorticotropin-independent macronodular adrenocortical hyperplasia associated with multiple colon adenomas/carcinomas which showed a point mutation in the APC gene. Internal Medicine. 1997;36:536–542
  22. Marchesa P, Fazio VW, Church JM, et al. Adrenal masses in patients with familial adenomatous polyposis. Diseases of the Colon and Rectum. 1997;40:1023–1028
  23. Matyakhina L, Freedman RJ, Bourdeau I, et al. Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical Cushing syndrome: a clinical and molecular genetic investigation. The Journal of Clinical Endocrinology and Metabolism. 2005;90:3773–3779
  24. Yamada Y, Sakaguchi K, Inoue T, et al. Preclinical Cushing's syndrome due to adrenocorticotropin-independent bilateral adrenocortical macronodular hyperplasia with concurrent excess of gluco- and mineralocorticoids. Internal Medicine. 1997;36:628–632
  25. Bourdeau I, D'Amour P, Hamet P, et al. Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome. The Journal of Clinical Endocrinology and Metabolism. 2001;86:5534–5540
  26. Ohashi A, Yamada Y, Sakaguchi K, et al. A natural history of adrenocorticotropin-independent bilateral adrenal macronodular hyperplasia (AIMAH) from preclinical to clinically overt Cushing's syndrome. Endocrine Journal. 2001;48:677–683
  27. Hayashi Y, Takeda Y, Kaneko K, et al. A case of Cushing's syndrome due to ACTH-independent bilateral macronodular hyperplasia associated with excessive secretion of mineralocorticoids. Endocrine Journal. 1998;45:485–491
  28. Malchoff CD, Rosa J, DeBold CR, et al. Adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia: an unusual cause of Cushing's syndrome. The Journal of Clinical Endocrinology and Metabolism. 1989;68:855–860
  29. Goodarzi MO, Dawson DW, Li X, et al. Virilization in bilateral macronodular adrenal hyperplasia controlled by luteinizing hormone. The Journal of Clinical Endocrinology and Metabolism. 2003;88:73–77
  30. Antonini SR, Baldacchino V, Tremblay J, et al. Expression of ACTH receptor pathway genes in glucose-dependent insulinotrophic peptide (GIP)-dependent Cushing's syndrome. Clinical Endocrinology. 2006;64:29–36
  31. Mircescu H, Jilwan J, N'Diaye N, et al. Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing's syndrome?. The Journal of Clinical Endocrinology and Metabolism. 2000;85:3531–3536
  32. Hsiao HP, Verma S, Boikos SA, et al. A molecular and clinical genetic investigation of ACTH-independent macronodular adrenal hyperplasia compared to other, common adrenocortical tumors: evidence for heterogeneity, overlap with other tumor syndromes and frequent but atypical hormonal secretion. Program of the 89th Annual Meeting of the Endocrine Society. Toronto: 2007. p 403, Abstract P2–299.
  33. Sasano H, Suzuki T, Nagura H. ACTH-independent macronodular adrenocortical hyperplasia: immunohistochemical and in situ hybridization studies of steroidogenic enzymes. Modern Pathology. 1994;7:215–219
  34. Aiba M, Kawakami M, Ito Y, et al. Bilateral adrenocortical adenomas causing Cushing's syndrome. Report of two cases with enzyme histochemical and ultrastructural studies and a review of the literature. Archives of Pathology & Laboratory Medicine. 1992;116:146–150
  35. Doppman JL, Nieman LK, Travis WD, et al. CT and MR imaging of massive macronodular adrenocortical disease: a rare cause of autonomous primary adrenal hypercortisolism. Journal of Computer Assisted Tomography. 1991;15:773–779
  36. Rockall AG, Babar SA, Sohaib SA, et al. CT and MR imaging of the adrenal glands in ACTH-independent Cushing syndrome. Radiographics. 2004;24:435–452
  37. N'Diaye N, Hamet P, Tremblay J, et al. Asynchronous development of bilateral nodular adrenal hyperplasia in gastric inhibitory polypeptide-dependent Cushing's syndrome. The Journal of Clinical Endocrinology and Metabolism. 1999;84:2616–2622
  38. Smals AG, Pieters GF, van Haelst UJ, et al. Macronodular adrenocortical hyperplasia in long-standing Cushing's disease. The Journal of Clinical Endocrinology and Metabolism. 1984;58:25–31
  39. Cugini P, Battisti P, Di Palma L, et al. ‘GIANT’ macronodular adrenal hyperplasia causing Cushing's syndrome: case report and review of the literature on a clinical distinction of adrenocortical nodular pathology associated with hypercortisolism. Endocrinologia Japonica. 1989;36:101–116
  40. Cheitlin RA, Westphal M, Cabrera , et al. Cushing's syndrome due to bilateral adrenal macronodular hyperplasia with undetectable ACTH: cell culture of adenoma cells on extracellular matrix. Hormone Research. 1988;29:162–167
  41. Light K, Jenkins PJ, Weber A, et al. Are activating mutations of the adrenocorticotropin receptor involved in adrenal cortical neoplasia?. Life Sciences. 1995;56:1523–1527
  42. Latronico AC, Reincke M, Mendonca BB, et al. No evidence for oncogenic mutations in the adrenocorticotropin receptor gene in human adrenocortical neoplasms. The Journal of Clinical Endocrinology and Metabolism. 1995;80:875–877
  43. Swords FM, Baig A, Malchoff DM, et al. Impaired desensitization of a mutant adrenocorticotropin receptor associated with apparent constitutive activity. Molecular Endocrinology. 2002;16:2746–2753
  44. Swords FM, Noon LA, King PJ, et al. Constitutive activation of the human ACTH receptor resulting from a synergistic interaction between two naturally occurring missence mutations in the MC2R gene. Molecular and Cellular Endocrinology. 2004;213:149–154
  45. Mauras N, Blizzard RM. The McCune-Albright syndrome. Acta Endocrinologica. Supplementum. 1986;279:207–217
  46. Aarskog D, Tveteraas E. McCune-Albright's syndrome following adrenalectomy for Cushing's syndrome in infancy. The Journal of Pediatrics. 1968;73:89–96
  47. Benjamin DR, McRoberts JW. Polyostotic fibrous dysplasia associated with Cushing syndrome. Archives of Pathology. 1973;96:175–178
  48. MacMahon HE. Albright's syndrome–thirty years later. (Polyostotic fibrous dysplasia). Pathology Annual. 1971;6:81–146
  49. Danon M, Robboy SJ, Kim S, et al. Cushing syndrome, sexual precocity, and polyostotic fibrous dysplasia (Albright syndrome) in infancy. The Journal of Pediatrics. 1975;87:917–921
  50. Fragoso MC, Domenice S, Latronico AC, et al. Cushing's syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene. The Journal of Clinical Endocrinology and Metabolism. 2003;88:2147–2151
  51. Lacroix A, Baldacchino V, Bourdeau I, et al. Cushing's syndrome variants secondary to aberrant hormone receptors. Trends in Endocrinology and Metabolism. 2004;15:375–382
  52. Bertagna X, Groussin L, Luton J-P, et al. Aberrant receptor-mediated Cushing's syndrome. Hormone Research. 2003;59(Suppl. 1):99–103
  53. Schorr I, Ney RL. Abnormal hormone responses of an adrenocortical cancer adenyl cyclase. The Journal of Clinical Investigation. 1971;50:1295–1300
  54. Lacroix A, Bolte E, Tremblay J, et al. Gastric inhibitory polypeptide-dependent cortisol hypersecretion–a new cause of Cushing's syndrome. The New England Journal of Medicine. 1992;327:974–980
  55. Reznik Y, Allali-Zerah V, Chayvialle JA, et al. Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. The New England Journal of Medicine. 1992;327:981–986
  56. Lebrethon MC, Avallet O, Reznik Y, et al. Food-dependent Cushing's syndrome: characterization and functional role of gastric inhibitory polypeptide receptor in the adrenals of three patients. The Journal of Clinical Endocrinology and Metabolism. 1998;83:4514–4519
  57. Groussin L, Perlemoine K, Contesse V, et al. The ectopic expression of the gastric inhibitory polypeptide receptor is frequent in adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia, but rare in unilateral tumors. The Journal of Clinical Endocrinology and Metabolism. 2002;87:1980–1985
  58. Croughs RJ, Zelissen PM, Van Vroonhoven ThJ, et al. GIP-dependent adrenal Cushing's syndrome with incomplete suppression of ACTH. Clinical Endocrinology. 2000;52:235–240
  59. Hamet P, Larochelle P, Franks DJ, et al. Cushing syndrome with food-dependent periodic hormonogenesis. Clinical and Investigative Medicine. 1987;10:530–533
  60. de Herder WW, Hofland LJ, Usdin TB, et al. Food-dependent Cushing's syndrome resulting from abundant expression of gastric inhibitory polypeptide receptors in adrenal adenoma cells. The Journal of Clinical Endocrinology and Metabolism. 1996;81:3168–3172
  61. Chabre O, Liakos P, Vivier J, et al. Cushing's syndrome due to a gastric inhibitory polypeptide-dependent adrenal adenoma: insights into hormonal control of adrenocortical tumorigenesis. The Journal of Clinical Endocrinology and Metabolism. 1998;83:3134–3143
  62. N'Diaye N, Tremblay J, Hamet P, et al. Adrenocortical overexpression of gastric inhibitory polypeptide receptor underlies food-dependent Cushing's syndrome. The Journal of Clinical Endocrinology and Metabolism. 1998;83:2781–2785
  63. Tsagarakis S, Tsigos C, Vassiliou V, et al. Food-dependent androgen and cortisol secretion by a gastric inhibitory polypeptide-receptor expressive adrenocortical adenoma leading to hirsutism and subclinical Cushing's syndrome: in vivo and in vitro studies. The Journal of Clinical Endocrinology and Metabolism. 2001;86:583–589
  64. Lampron A, Bourdeau I, Hamet P, et al. Whole genome expression profiling of glucose-dependent insulinotropic peptide (GIP)- and adrenocorticotropin-dependent adrenal hyperplasias reveals novel targets for the study of GIP-dependent Cushing's syndrome. The Journal of Clinical Endocrinology and Metabolism. 2006;91:3611–3618
  65. Bertherat J, Contesse V, Louiset E, et al. In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism. The Journal of Clinical Endocrinology and Metabolism. 2005;90:1302–1310
  66. Swords FM, Aylwin S, Perry L, et al. The aberrant expression of the gastric inhibitory polypeptide (GIP) receptor in adrenal hyperplasia: does chronic adrenocorticotropin exposure stimulate up-regulation of GIP receptors in Cushing's disease?. The Journal of Clinical Endocrinology and Metabolism. 2005;90:3009–3016
  67. Baldacchino V, Oble S, Decarie PO, et al. The Sp transcription factors are involved in the cellular expression of the human glucose-dependent insulinotropic polypeptide receptor gene and overexpressed in adrenals of patients with Cushing's syndrome. Journal of Molecular Endocrinology. 2005;35:61–71
  68. Mazzuco TL, Chabre O, Sturm N, et al. Ectopic expression of the gastric inhibitory polypeptide receptor gene is a sufficient genetic event to induce benign adrenocortical tumor in a xenotransplantation model. Endocrinology. 2006;147:782–790
  69. Perraudin V, Delarue C, De Keyzer Y, et al. Vasopressin-responsive adrenocortical tumor in a mild Cushing's syndrome: in vivo and in vitro studies. The Journal of Clinical Endocrinology and Metabolism. 1995;80:2661–2667
  70. Horiba N, Suda T, Aiba M, et al. Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia. The Journal of Clinical Endocrinology and Metabolism. 1995;80:2336–2341
  71. Iida K, Kaji H, Matsumoto H, et al. Adrenocorticotrophin-independent macronodular adrenal hyperplasia in a patient with lysine vasopressin responsiveness but insensitivity to gastric inhibitory polypeptide. Clinical Endocrinology. 1997;47:739–745
  72. Lacroix A, Tremblay J, Touyz RM, et al. Abnormal adrenal and vascular responses to vasopressin mediated by a V1- vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing's syndrome, and orthostatic hypotension. The Journal of Clinical Endocrinology and Metabolism. 1997;82:2414–2422
  73. Daidoh H, Morita H, Hanafusa J, et al. In vivo and in vitro effects of AVP and V1a receptor antagonist on Cushing's syndrome due to ACTH-independent bilateral macronodular adrenocortical hyperplasia. Clinical Endocrinology. 1998;49:403–409
  74. Arnaldi G, Gasc JM, de Keyzer Y, et al. Variable expression of the V1 vasopressin receptor modulates the phenotypic response of steroid-secreting adrenocortical tumors. The Journal of Clinical Endocrinology and Metabolism. 1998;83:2029–2035
  75. Mune T, Murase H, Yamakita N, et al. Eutopic overexpression of vasopressin v1a receptor in adrenocorticotropin-independent macronodular adrenal hyperplasia. The Journal of Clinical Endocrinology and Metabolism. 2002;87:5706–5713
  76. Louiset E, Contesse V, Groussin L, et al. Expression of vasopressin receptors in ACTH-independent macronodular bilateral adrenal hyperplasia causing Cushing's syndrome: molecular, immunohistochemical and pharmacological correlates. The Journal of Endocrinology. 2008;196:1–9
  77. Lacroix A, Tremblay J, Rousseau G, et al. Propranolol therapy for ectopic beta-adrenergic receptors in adrenal Cushing's syndrome. The New England Journal of Medicine. 1997;337:1429–1434
  78. Miyamura N, Tsutsumi A, Senokuchi H, et al. A case of ACTH-independent macronodular adrenal hyperplasia: simultaneous expression of several aberrant hormone receptors in the adrenal gland. Endocrine Journal. 2003;50:333–340
  79. Lacroix A, Hamet P, Boutin JM. Leuprolide acetate therapy in luteinizing hormone–dependent Cushing's syndrome. The New England Journal of Medicine. 1999;341:1577–1581
  80. Feelders RA, Lamberts SW, Hofland LJ, et al. Luteinizing hormone (LH)-responsive Cushing's syndrome: the demonstration of LH receptor messenger ribonucleic acid in hyperplastic adrenal cells, which respond to chorionic gonadotropin and serotonin agonists in vitro. The Journal of Clinical Endocrinology and Metabolism. 2003;88:230–237
  81. Cartier D, Lihrmann I, Parmentier F, et al. Overexpression of serotonin4 receptors in cisapride-responsive adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia causing Cushing's syndrome. The Journal of Clinical Endocrinology and Metabolism. 2003;88:248–254
  82. Mannelli M, Ferruzzi P, Luciani P, et al. Cushing's syndrome in a patient with bilateral macronodular adrenal hyperplasia responding to cisapride: an in vivo and in vitro study. The Journal of Clinical Endocrinology and Metabolism. 2003;88:4616–4622
  83. Louiset E, Contesse V, Groussin L, et al. Expression of serotonin7 receptor and coupling of ectopic receptors to protein kinase A and ionic currents in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome. The Journal of Clinical Endocrinology and Metabolism. 2006;91:4578–4586
  84. Nakamura Y, Son Y, Kohno Y, et al. Case of adrenocorticotropic hormone-independent macronodular adrenal hyperplasia with possible adrenal hypersensitivity to angiotensin II. Endocrine. 2001;15:57–61
  85. Pralong FP, Gomez F, Guillou L, et al. Food-dependent Cushing's syndrome: possible involvement of leptin in cortisol hypersecretion. The Journal of Clinical Endocrinology and Metabolism. 1999;84:3817–3822
  86. Hashimoto K, Kawada Y, Murakami K, et al. Cortisol responsiveness to insulin-induced hypoglycemia in Cushing's syndrome with huge nodular adrenocortical hyperplasia. Endocrinologia Japonica. 1986;33:479–487
  87. Makino S, Hashimoto K, Sugiyama M, et al. Cushing's syndrome due to huge nodular adrenocortical hyperplasia with fluctuation of urinary 17-OHCS excretion. Endocrinologia Japonica. 1989;36:655–663
  88. Louisset E, Duparc, Groussin L, et al. Abnormal sensitivity of cortisol secretion to glucagon in primary adrenal Cushing's syndrome. Proceedings, XIII Adrenal cortex conference. San Francisco: June 11-14 2008. p 52, abstract 33.
  89. Imohl M, Koditz R, Stachon A, et al. Catecholamine-dependent hereditary Cushing's syndrome - follow-up after unilateral adrenalectomy. Medizinische Klinik (Munich). 2002;97:747–753
  90. Antonini SR, N'Diaye N, Baldacchino V, et al. Analysis of the putative regulatory region of the gastric inhibitory polypeptide receptor gene in food-dependent Cushing's syndrome. The Journal of Steroid Biochemistry and Molecular Biology. 2004;91:171–177
  91. Bourdeau I, Antonini SR, Lacroix A, et al. Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators. Oncogene. 2004;23:1575–1585
  92. Mazzuco TL, Chabre O, Feige JJ, et al. Aberrant expression of human luteinizing hormone receptor by adrenocortical cells is sufficient to provoke both hyperplasia and Cushing's syndrome features. The Journal of Clinical Endocrinology and Metabolism. 2006;91:196–203
  93. Bourdeau I, Matyakhina L, Stergiopoulos SG, et al. 17q22-24 chromosomal losses and alterations of protein kinase a subunit expression and activity in adrenocorticotropin-independent macronodular adrenal hyperplasia. The Journal of Clinical Endocrinology and Metabolism. 2006;91:3626–3632
  94. Lefebvre H, Duparc C, Chartrel N, et al. Intraadrenal adrenocorticotropin production in a case of bilateral macronodular adrenal hyperplasia causing Cushing's syndrome. The Journal of Clinical Endocrinology and Metabolism. 2003;88:3035–3042
  95. Lacroix A, Mircescu H, Hamet P. Clinical evaluation of the presence of abnormal hormone receptors in adrenal Cushing's syndrome. The Endocrinologist. 1999;9:9–15
  96. Reznik Y, Lefebvre H, Rohmer V, et al. Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study. Clinical Endocrinology. 2004;61:311–313
  97. Boronat M, Lucas T, Barcelo B, et al. Cushing's syndrome due to autonomous macronodular adrenal hyperplasia: long-term follow-up after unilateral adrenalectomy. Postgraduate Medical Journal. 1996;72:614–616
  98. Lamas C, Alfaro JJ, Lucas T, et al. Is unilateral adrenalectomy an alternative treatment for ACTH-independent macronodular adrenal hyperplasia?: Long-term follow-up of four cases. European Journal of Endocrinology. 2002;146:237–240

PII: S1521-690X(08)00118-8

doi: 10.1016/j.beem.2008.10.011

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 2 , Pages 245-259 , April 2009

Article Tools

* Image Usage & Resolution